Skip to main content
Fig. 3 | Journal for ImmunoTherapy of Cancer

Fig. 3

From: miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer

Fig. 3

IDO1 suppresses the CD8+ T cell response in subcutaneous tumor tissue. a Immunohistochemical staining for IDO1, CD8 and NCR1 in sections of mouse tumor tissues from the pLenti-IDO1 group and the pLenti-Vector group. Top, representative pictures; bottom, quantitative data. Data represent the relative percentage of IDO1+, CD8+ and NCR1+ cells in the pLenti-IDO1 group to that in the pLenti-Vector group. Scale bars: 20 μm. b Representative pictures of immunofluorescent staining for IDO1 expression tumor cells and infiltrating CD8+ lymphocytes in sections of mouse tumor tissues from the pLenti-IDO1 group and the pLenti-Vector group. Blue, DAPI staining; red, IDO1 staining; green, CD8 staining. Scale bars: 20 μm. c FACS analysis of CD8+ T cells and CD4+ T cells in CD45+ cells of mice tumor tissues in the pLenti-IDO1 group and pLenti-Vector group. Left, representative pictures; right, quantitative data. a Mean ± SEM; c mean ± SD. a-c n = 5. a, c Two-tailed Student’s t-test was performed for statistical analysis; *P < 0.05, ***P < 0.001, NS: not significant

Back to article page